# This Fortnight in Medicine X

Page: https://stenobird.com/podcast/sensible-medicine-5998897/this-fortnight-in-medicine-x
Text version: https://stenobird.com/podcast/sensible-medicine-5998897/this-fortnight-in-medicine-x.md
Podcast: [Sensible Medicine](https://stenobird.com/podcast/sensible-medicine-5998897)
Published: 2025-10-08T09:00:00+00:00
Episode link: https://www.sensible-med.com/p/this-fortnight-in-medicine-x
Audio file: https://api.substack.com/feed/podcast/175050005/5bf0eefdd453bff578cee781482621b4.mp3
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/sensible-medicine-5998897/episodes/this-fortnight-in-medicine-x
Duration seconds: 3052

## Resource

Two papers this week, with a bunch of articles that we referenced in the conversation. Also, the last Fortnight podcast was accidentally posted behind a paywall. It is now up and free to listen to. My apologies. Sensible Medicine is reader-supported. If you appreciate our work, consider becoming a free or paid subscriber. Folinic acid improves verbal communication in children with autism and language impairment: a randomized double-blind placebo-controlled trial * Folate Receptor Alpha Autoantibodies in Autism Spectrum Disorders: Diagnosis, Treatment and Prevention * Association Between Maternal Use of Folic Acid Supplements and Risk of Autism Spectrum Disorders in Children * Cerebral folate receptor autoantibodies in autism spectrum disorder * What Is Leucovorin, the Medicine Being Approved for Autism Treatment? * Clinicaltrial.gov search Effects of Glucagon-Like Peptide 1 Receptor Agonist Initiation in Patients With Heart Failure With Reduced Ejection Fraction and Implantable Cardiac Devices * Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes * Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes * Effects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction * Increased Risk of Heart Failure Hospitalization With GLP-1 Receptor Agonists in Patients With Reduced Ejection Fraction: A Meta-Analysis of the EXSCEL and FIGHT Trials This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.sensible-med.com/subscribe

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/sensible-medicine-5998897/episodes/this-fortnight-in-medicine-x/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/sensible-medicine-5998897/this-fortnight-in-medicine-x.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.